These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Guidelines for pharmacists performing product selection. Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394 [No Abstract] [Full Text] [Related]
6. Patient package inserts and the pharmacist's responsibility. Fink JL Am J Hosp Pharm; 1979 Feb; 36(2):226-9. PubMed ID: 420215 [TBL] [Abstract][Full Text] [Related]
7. Understanding drug product selection legislation. Berger BA Contemp Pharm Pract; 1981; 4(2):89-93. PubMed ID: 10250914 [TBL] [Abstract][Full Text] [Related]
8. Attitudes of pharmacists and physicians toward Florida's drug product selection law. Vuturo GJ; McCormick WC; Krischer JP Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871 [TBL] [Abstract][Full Text] [Related]
9. Potential and actual drug product selection rates in Florida. Vuturo GJ; McCormick WC; Krischer JP Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872 [TBL] [Abstract][Full Text] [Related]
10. Measuring statutory effectiveness and compliance with Rhode Island's Drug Product Selection law. Campbell NA; DiLorenzo AW; Hachadorian C; Scott MD R I Med J (1976); 1986 Dec; 69(12):585-8. PubMed ID: 3468594 [No Abstract] [Full Text] [Related]
11. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle. Felch WC Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131 [No Abstract] [Full Text] [Related]
12. Forces and direction of drug product selection legislation. Stewart JE Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281 [No Abstract] [Full Text] [Related]
13. Drug product selection legislation: a comparative analysis. Wetherbee H; Sharpe TR Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098 [No Abstract] [Full Text] [Related]
14. Drug product selection: legal issues. Christensen TP; Kirking DM; Ascione FJ; Welage LS; Gaither CA J Am Pharm Assoc (Wash); 2001; 41(6):868-74. PubMed ID: 11765112 [TBL] [Abstract][Full Text] [Related]
16. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation? Willig SH Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590 [No Abstract] [Full Text] [Related]
17. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists. Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108 [TBL] [Abstract][Full Text] [Related]
18. Legal implications of the pharmacist's expanded clinical roles: a challenge to the clinical pharmacist's competencies. Moore RC; Mikeal RL; Brewer BF; Burton SF Contemp Pharm Pract; 1979; 2(3):132-5. PubMed ID: 10297530 [TBL] [Abstract][Full Text] [Related]
19. Economic issues in the antisubstitution controversy. Sharpe TR Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879 [No Abstract] [Full Text] [Related]
20. Editorial: The pharmacist and drug product selection. Tice LF Am J Pharm Sci Support Public Health; 1974; 146(3):67-9. PubMed ID: 4851580 [No Abstract] [Full Text] [Related] [Next] [New Search]